Qingdao Vland Biotech INC.
SSE:603739.SS
13.97 (CNY) • At close June 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 248.727 | 239.595 | 213.87 | 311.832 | 249.918 | 174.051 | 159.66 | 175.292 | 130.231 | 107.324 | 115.473 |
| Short Term Investments
| 199.344 | 292.047 | 212.02 | 170.433 | 97.455 | 182.903 | 22.742 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 448.072 | 531.642 | 425.889 | 482.265 | 347.372 | 356.955 | 159.66 | 175.292 | 130.231 | 107.324 | 115.473 |
| Net Receivables
| 405.263 | 330.263 | 307.722 | 254.314 | 193.553 | 174.983 | 156.479 | 142.812 | 160.885 | 167.865 | 130.836 |
| Inventory
| 188.95 | 205.405 | 173.634 | 157.025 | 124.725 | 106.226 | 98.569 | 87.333 | 77.704 | 71.01 | 82.865 |
| Other Current Assets
| 26.909 | 56.63 | 62.155 | 78.219 | 76.574 | 67.741 | 48.712 | 33.788 | 37.748 | 42.337 | 65.85 |
| Total Current Assets
| 1,069.195 | 1,123.941 | 969.399 | 971.823 | 742.224 | 705.905 | 460.495 | 439.225 | 406.568 | 388.536 | 395.025 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 1,560.232 | 1,576.197 | 1,259.882 | 843.515 | 501.014 | 390.995 | 367.552 | 328.349 | 311.387 | 314.337 | 318.451 |
| Goodwill
| 84.202 | 84.202 | 20.257 | 20.257 | 9.897 | 9.897 | 9.897 | 9.897 | 9.897 | 9.897 | 9.897 |
| Intangible Assets
| 131.128 | 139.745 | 135.632 | 131.462 | 122.247 | 74.938 | 76.336 | 75.507 | 70.122 | 80.867 | 64.651 |
| Goodwill and Intangible Assets
| 215.33 | 223.947 | 155.889 | 151.719 | 132.144 | 84.835 | 86.233 | 85.404 | 80.019 | 90.763 | 74.548 |
| Long Term Investments
| -100.704 | 80.843 | -134.83 | -161.846 | -81.311 | -164.498 | 0 | 22.742 | 22.742 | 21.95 | 1.081 |
| Tax Assets
| 16.99 | 18.061 | 13.636 | 12.03 | 8.913 | 10.87 | 8.299 | 7.825 | 7.207 | 6.043 | 5.687 |
| Other Non-Current Assets
| 219.958 | 11.068 | 314.872 | 404.52 | 148.484 | 253.143 | 22.742 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets
| 1,911.806 | 1,910.116 | 1,609.448 | 1,249.938 | 709.243 | 575.345 | 484.826 | 444.32 | 421.356 | 433.093 | 399.766 |
| Total Assets
| 2,981.001 | 3,034.058 | 2,578.848 | 2,221.761 | 1,451.468 | 1,281.25 | 945.321 | 883.545 | 827.924 | 821.629 | 794.791 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 224.559 | 225.774 | 147.357 | 112.109 | 86.738 | 65.16 | 67.674 | 65.211 | 65.555 | 59.052 | 56.647 |
| Short Term Debt
| 581.634 | 568.971 | 374.216 | 135.928 | 67.83 | 36.9 | 105 | 75 | 15 | 65 | 100 |
| Tax Payables
| 18.85 | 8.435 | 26.473 | 16.772 | 6.666 | 7.386 | 10.952 | 12.11 | 13.965 | 9.995 | 11.182 |
| Deferred Revenue
| 0 | 0 | 7.488 | 115.537 | 112.714 | 76.531 | 10.952 | 80.247 | 101.437 | 74.841 | 67.078 |
| Other Current Liabilities
| 206.407 | 284.994 | 89.552 | -8.021 | 99.134 | -2.2 | 68.928 | 74.224 | 5.618 | 86.698 | 60.056 |
| Total Current Liabilities
| 1,031.449 | 1,088.174 | 645.086 | 372.326 | 272.795 | 183.778 | 252.555 | 226.545 | 201.574 | 220.744 | 227.884 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 13.956 | 62.06 | 149 | 99 | 0 | 6.524 | 1.68 | 3 | 0 | 15 | 30 |
| Deferred Revenue Non-Current
| 63.97 | 0 | 47.955 | 60.454 | 55.664 | 57.407 | 59.71 | 61.474 | 65.383 | 66.523 | 70.65 |
| Deferred Tax Liabilities Non-Current
| 1.457 | 3.022 | 2.722 | 2.877 | 1.236 | 1.283 | 0 | 0 | 0 | -15 | -30 |
| Other Non-Current Liabilities
| 0.152 | 55.416 | 0.172 | 1.52 | 6.524 | 0 | 0 | 0 | 68.383 | 0 | 0 |
| Total Non-Current Liabilities
| 79.535 | 120.498 | 199.849 | 163.85 | 63.424 | 65.214 | 61.39 | 64.474 | 68.383 | 81.523 | 100.65 |
| Total Liabilities
| 1,110.984 | 1,208.672 | 844.934 | 536.176 | 336.22 | 248.992 | 313.944 | 291.019 | 269.957 | 302.268 | 328.535 |
| Equity: | |||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 253.029 | 253.029 | 252.442 | 252.085 | 154.667 | 154.667 | 116 | 116 | 116 | 116 | 116 |
| Retained Earnings
| 740.812 | 703.477 | 656.586 | 627.077 | 531.413 | 463.361 | 418.862 | 399.304 | 378.385 | 351.071 | 306.806 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 45.452 | 39.521 | 39.685 | 34.78 | 34.228 | 28.352 | 21.646 | 16.409 | 0 |
| Other Total Stockholders Equity
| 743.88 | 751.787 | 752.627 | 741.379 | 308.358 | 346.023 | 34.636 | 0.603 | 0.458 | 0.458 | 11.408 |
| Total Shareholders Equity
| 1,737.721 | 1,708.293 | 1,644.694 | 1,604.516 | 1,034.123 | 962.185 | 569.693 | 544.259 | 516.489 | 483.938 | 434.215 |
| Total Equity
| 1,870.016 | 1,825.386 | 1,733.913 | 1,685.585 | 1,115.248 | 1,032.258 | 631.377 | 592.526 | 557.966 | 519.361 | 466.256 |
| Total Liabilities & Shareholders Equity
| 2,981.001 | 3,034.058 | 2,578.848 | 2,221.761 | 1,451.468 | 1,281.25 | 945.321 | 883.545 | 827.924 | 821.629 | 794.791 |